SB's Diversified Pharma Services Buys PDS

27 February 1995

SmithKline Beecham's US pharmacy benefit management subsidiary, Diversified Pharmaceutical Services, has purchased Prescription Delivery Systems, a mail-order prescription pharmaceutical company based in Horsham, Pennsylvania. The move is in response to the market's increasing demand for mail-order prescription drugs, which currently account for about 15% of pharmaceutical purchases, says SB. Terms of the deal are not disclosed, but it is thought to be under $50 million.

At present, PDS has a level of technological sophistication unsurpassed in its field and is well equipped to handle expanded demand, according to SB, and DPS' chief executive Travers Wills stressed that the new mail-order capability will supplement, not replace, Diversified's primary delivery system - community pharmacies.

He said the acquisition is a strategic move, providing "a capability to deliver an essential service and allowing us to compete more effectively in the marketplace." Many Health Maintenance Organizations and major employers view mail-order pharmaceuticals as a way of lowering total drug costs for members or employees, he added, and the group can now offer a range of strategies aimed at reducing drug spending.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight